Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Asymchem Laboratories (Tianjin) Co., Ltd.
  6. News
  7. Summary
    002821   CNE100002BZ6

ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.

(002821)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

China stocks slip as healthcare firms retreat; Hong Kong up

06/24/2021 | 12:31am EDT

* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%

* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%

* FTSE China A50 -0.1%

SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.

** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.

** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.

** Hengrui, Guangzhou Kingmed Diagnostics Group Co Ltd, Asymchem Laboratories Tianjin Co Ltd , Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.

** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.

** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.

** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.

** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.

** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.

** Hoshine Silicon tumbled 9.9% after the U.S. ban.

** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86. (Reporting by Luoyan Liu and Andrew Galbraith; Editing by Aditya Soni)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. -3.41% 399.08 End-of-day quote.33.41%
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED -6.35% 172 End-of-day quote.17.46%
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. -4.84% 98.6 End-of-day quote.-23.04%
HANG SENG 0.40% 25389.13 Real-time Quote.-7.13%
HOSHINE SILICON INDUSTRY CO., LTD. 2.58% 173.88 End-of-day quote.419.98%
JIANGSU HENGRUI MEDICINE CO., LTD. -1.90% 49.1 End-of-day quote.-47.14%
All news about ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
09/16Asymchem and LaNova Medicines Enter into Partnership Agreement, Expanding Biological Ca..
CI
08/15Asymchem Laboratories Tianjin Co., Ltd. Reports Earnings Results for the Half Year Ende..
CI
07/07Asymchem Laboratories Co., Ltd. Announces Final Cash Dividend for 2020 on its A Shares,..
CI
07/02Tianjin Yugen Medtech Development Co., Ltd. announced that it expects to receive CNY 10..
CI
06/24China stocks slip as healthcare firms retreat; Hong Kong up
RE
05/19Asymchem Laboratories Co., Ltd. Announces Dividend for 2020
CI
04/16Asymchem Laboratories Co., Ltd. Announces Final Dividend for 2020
CI
04/15Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
03/25Asymchem Expands Manufacturing Capacity for Oligonucleotides
CI
02/10Asymchem Laboratories Co., Ltd. Elects Zhang Ting as Non-Independent Director
CI
More news
Financials
Sales 2021 4 216 M 656 M 656 M
Net income 2021 975 M 152 M 152 M
Net cash 2021 9 022 M 1 403 M 1 403 M
P/E ratio 2021 99,3x
Yield 2021 0,18%
Capitalization 96 827 M 15 060 M 15 061 M
EV / Sales 2021 20,8x
EV / Sales 2022 16,2x
Nbr of Employees 5 600
Free-Float 56,8%
Chart ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Duration : Period :
Asymchem Laboratories (Tianjin) Co., Ltd. Technical Analysis Chart | 002821 | CNE100002BZ6 | MarketScreener
Technical analysis trends ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 399,08 CNY
Average target price 415,96 CNY
Spread / Average Target 4,23%
EPS Revisions
Managers and Directors
Hao Hong Chairman & General Manager
Da Zhang CFO, Director & Deputy General Manager
Ting Zhang Chairman-Supervisory Board
Kun Zhang Independent Director
Guang Cheng Pan Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.33.41%15 578
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657